...
机译:基于Everolimus的免疫抑制可能抑制初级肾移植后De Novo供体特异性抗体的平均荧光强度值
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Surg Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Surg Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Nephrol Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Surg Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Nephrol Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Surg Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Nephrol Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Kidney Dis Ctr Transplant Surg Nagoya Aichi Japan;
Masuko Mem Hosp Div Kidney Transplant Nagoya Aichi Japan;
Japanese Red Cross Nagoya Daini Hosp Div Labs Nagoya Aichi Japan;
Aichi Med Hosp Dept Kidney Transplant Nagoya Aichi Japan;
机译:基于Everolimus的免疫抑制可能抑制初级肾移植后De Novo供体特异性抗体的平均荧光强度值
机译:单固定的低剂量蓖麻油肢体作为感应治疗抑制了ABO相容生活肾移植受者的De Novo供体特异性抗HLA抗体产生
机译:使用Luminex进行的从头进行C3d固定II类供体特异性抗体的系统筛选与肾脏移植患者的Luminex平均荧光强度相关
机译:ABO-Indompative肾移植中的供体特异性抑制血型抗体
机译:小儿肾移植受者的EPLET不匹配和De Novo供体特异性抗体发育
机译:基于依维莫司的双重免疫抑制与标准护理在新生肾移植受者中的随机对照试验
机译:单固定低剂量蓖麻油肢体作为感应治疗抑制了ABO兼容的肾移植受者的De Novo供体特异性抗HLA抗体产生